Tesla has finally unveiled its cheaper EV options which aims at the more budget conscious buyer. It isn’t a new smaller model but a new base-spec Standard variant for its popular Model 3 and Model Y.

Not much has gone right for Walgreens Boots Alliance in the past decade. Customers bought more and more household items online at sites such as Amazon.com, instead of Walgreens’s more than 8,000 ...

Deal talk was in the air again around Walgreens and suitor Sycamore Partners. Discussions have been going on since late last year. A possible three-way split of the business is in the offing. News ...

Abstract: Fingerprint localization methods typically require a substantial amount of manual effort to collect fingerprint data from various scenarios to construct an accurate radio map. While some ...

The 2025 Porsche 911 Carrera T debuts for the new 992.2 generation, and it's now offered as a convertible for the first time. The T now only comes with a manual transmission, and the six-speed unit ...

My daughter is especially sensitive to dry air in the winter, and I’m learning that summer pollen has the same negative effect. With pollen levels increasing alarmingly every year, more and more kids ...

The retail pharmacy giant and the Biomedical Advanced Research and Development Authority hope to make decentralized clinical trials more accessible and representative of the U.S. population. The U.S.

This first-of-its-kind collaboration between Walgreens (WBA) and U.S. government aims to address barriers in decentralized clinical trial access and conduct trials over a five-year period, valued up ...

Ask the publishers to restore access to 500,000+ books. A line drawing of the Internet Archive headquarters building façade. An illustration of a heart shape "Donate to the archive" An illustration of ...

The article discusses Walgreen's challenges with its core business model. WBA is struggling against competitors like Costco, CVS, and Walmart. Walgreens still looks overvalued. It had negative free ...

A research team based at the University of California, San Diego presented data from a study that evaluated the novel cyclophilin D (CypD) inhibitor CC-2055 in preclinical models of epilepsy.